IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients

导出原文传递学术成果认领

作者单位 Department of Clinical Pharmacology, Xiangya Hospital Central South University, Changsha 410008, China;Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China;Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China;Institute of Clinical Pharmacy, Central South University, Changsha 410011, China ^[1] International Medical Department, Xiangya Hospital, Central South University, Changsha 410008, China ^[2] Department of Clinical Pharmacology, Xiangya Hospital Central South University, Changsha 410008, China;Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China ^[3] Peking University Third Hospital, Beijing 100191, China ^[4]

关键词 tacrolimus Chinese kidney transplant recipients individualized therapy dose-adjusted concentration gene polymorphism CYP IL-3 CTLA4

栏目名称 Clinical Pharmacology

DOI 10.1038/aps.2016.153

发布时间 2017-03-31

浏览0
被引17
下载0

中国药理学报（英文版）

2017年38卷3期

415-423页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

检索历史清除